Stand out for this role — generate a tailored resume and cover letter in about a minute.
IntegriChain is seeking a Director, Advisory - 340B Drug Pricing Program to lead strategic and analytical consulting engagements. You will guide 340B growth analyses and model development using healthcare data, while staying ahead of regulatory changes affecting government pricing programs.
Ideal candidates bring 10+ years of experience, deep knowledge of the 340B landscape, and strong communication skills to convey insights to manufacturers and internal teams.
IntegriChain is the data and application backbone for market access departments of Life Sciences manufacturers. We deliver the data, the applications, and the business process infrastructure for patient access and therapy commercialization. More than 250 manufacturers rely on our ICyte Platform to orchestrate their commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, Life Sciences innovators can digitalize their market access operations, freeing up resources to focus on more data-driven decision support. With ICyte, Life Sciences innovators are digitalizing labor-intensive processes – freeing up their best talent to identify and resolve coverage and availability hurdles and to manage pricing and forecasting complexity.
IntegriChain is the data and application backbone for market access departments of Life Sciences manufacturers. We deliver the data, the applications, and the business process infrastructure for patient access and therapy commercialization. More than 250 manufacturers rely on our ICyte Platform to orchestrate their commercial and government payer contracting, patient services, and distribution channels. ICyte is the first and only platform that unites the financial, operational, and commercial data sets required to support therapy access in the era of specialty and precision medicine. With ICyte, Life Sciences innovators can digitalize their market access operations, freeing up resources to focus on more data-driven decision support. With ICyte, Life Sciences innovators are digitalizing labor-intensive processes – freeing up their best talent to identify and resolve coverage and availability hurdles and to manage pricing and forecasting complexity. We are headquartered in Philadelphia, PA (USA), with offices in: Ambler, PA (USA); Pune, India; and Medellín, Colombia. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
IntegriChain supports and advises pharmaceutical manufacturers as they navigate the complexities of government healthcare programs, with a particular focus on the 340B Drug Pricing Program. Our team is an established leader in technology solutions for net revenue management and 340B channel management, and we support a client base that includes the largest pharmaceutical manufacturers in the US as well as early-stage biotech companies. Beyond our syndicated solutions, we also integrate and synthesize data to deliver unparalleled analytics and insights into various aspects of the 340B Drug Pricing Program and the pharmaceutical supply chain. The Director, Advisory - 340B Drug Pricing Program role will lead strategic, operational, and analytical consulting engagements that help pharmaceutical manufacturers optimize their approach to the 340B Drug Pricing Program and related government pricing initiatives.
Mission driven: Work with the purpose of helping to improve patients' lives!
All your information will be kept confidential according to EEO guidelines.
Blue Fin Group is committed to equal treatment and opportunity in all aspects of recruitment, selection, and employment without regard to race, color, religion, national origin, ethnicity, age, sex, marital status, physical or mental disability, gender identity, sexual orientation, veteran or military status, or any other category protected under the law. Blue Fin Group is an equal opportunity employer; committed to creating a community of inclusion, and an environment free from discrimination, harassment, and retaliation.
IntegriChain is committed to equal treatment and opportunity in all aspects of recruitment, selection, and employment without regard to race, color, religion, national origin, ethnicity, age, sex, marital status, physical or mental disability, gender identity, sexual orientation, veteran or military status, or any other category protected under the law. IntegriChain is an equal opportunity employer; committed to creating a community of inclusion, and an environment free from discrimination, harassment, and retaliation.
Our policy on visa sponsorship for US based positions: Applicants for employment in the US must have valid work authorization that does not now and/or will not in the future require sponsorship of a visa for employment authorization in the US by Blue Fin Group.
Our policy on visa sponsorship for US based positions: Applicants for employment in the US must have valid work authorization that does not now and/or will not in the future require sponsorship of a visa for employment authorization in the US by IntegriChain.